RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Control and Elimination of Schistosomiasis as a Public Health Problem
Thresholds Fail to Differentiate Schistosomiasis Morbidity Prevalence in Children
Wiegand, R. E., Secor, W. E., Fleming, F. M., French, M. D., King, C. H., Montgomery, S. P., Evans, D., Utzinger, J., Vounatsou, P., & de Vlas, S. J. (2021). Control and Elimination of Schistosomiasis as a Public Health Problem: Thresholds Fail to Differentiate Schistosomiasis Morbidity Prevalence in Children. Open Forum Infectious Diseases, 8(7), Article 179. https://doi.org/10.1093/ofid/ofab179
Background. Current World Health Organization guidelines utilize prevalence of heavy-intensity infections (PHIs), that is, >= 50 eggs per 10 mL of urine for Schistosoma haematobium and >= 400 eggs per gram of stool for S. mansoni, to determine whether a targeted area has controlled schistosomiasis morbidity or eliminated schistosomiasis as a public health problem. The relationship between these PHI categories and morbidity is not well understood.
Methods. School-age participants enrolled in schistosomiasis monitoring and evaluation cohorts from 2003 to 2008 in Burkina Faso, Mali, Niger, Tanzania, Uganda, and Zambia were surveyed for infection and morbidity at baseline and after 1 and 2 rounds of preventive chemotherapy. Logistic regression was used to compare morbidity prevalence among participants based on their school's PHI category.
Results. Microhematuria levels were associated with the S. haematobium PHI categories at all 3 time points. For any other S. haematobium or S. mansoni morbidity that was measured, PHI categories did not differentiate morbidity prevalence levels consistently.
Conclusions. These analyses suggest that current PHI categorizations do not differentiate the prevalence of standard morbidity markers. A reevaluation of the criteria for schistosomiasis control is warranted.
